Gausspeed Generative AI Platform – Announced in April 2024, Gausspeed was developed in collaboration with Heartdub, a U.S.-based leader in physical simulation technology. Leveraging NVIDIA Omniverse ...

PhaseV, a leader in AI/ML-driven clinical development, announced today that it will demonstrate new capabilities of its ...

PhaseV, a leader in AI/ML-driven clinical development, announced today that it will demonstrate new capabilities of its platform for clinical trials at the upcoming Chief Medical Officer (CMO) Summit ...

Traverse Research, one of the leading companies in graphics research and development, today announced the global launch of Evolve, a groundbreaking GPU benchmark suite designed to adapt to the rapidly ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...